- Investing Ideas
- /
- Australian Biotech Breakthroughs
Australian Biotech Breakthroughs
Results
3
0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
3 companies
Immutep
Market Cap: AU$430.8m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.29
7D
-3.3%
1Y
-33.7%
Aroa Biosurgery
Market Cap: AU$155.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.45
7D
2.3%
1Y
-8.2%
PYC Therapeutics
Market Cap: AU$699.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.20
7D
-3.2%
1Y
0%